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Background
Subtype-C alone accounts for approximately 50% of glo-
bal and more than 95% human immunodeficiency virus-
1 (HIV-1) infection in India. Identification of antigenic
epitopes that induce antibodies with cross-clade activity
will be crucial to address the HIV-1 viral diversity.
Methods
80 HIV-1 infected drug naive patients were recruited for
this study. The study was approved by the institute
ethics committee and informed consent was obtained
from all the participants. The relative binding of anti-V3
polyclonal plasma antibodies to 35 mer consensus-B and
C V3 peptides was done by ELISA binding assay. Statis-
tical analysis was performed by Graphpad Prism 5.
Results
Assessment of the relative binding revealed that 86%
(69/80) and 99% (79/80) of the plasma were able to
reach an IC50 binding titer with V3B peptide and V3C
peptides respectively; with substantially low antibody
titers that bind to V3B than V3C (mean IC50,
V3B=2736 versus V3C=12612) (p<0.0001). The finding
suggests that although majority of the antibodies were
subtype specific, a good proportion of cross reactive
anti-V3 antibodies also exist in these plasma
(mean=23% range=0.11-97%). We observed a positive
correlation between percent cross reactive anti-V3 anti-
bodies and days from first diagnosis (p=0.008) while no
such association was found with other clinical and
immunological parameters like plasma viral load
(p=0.24), CD4 count (p=0.34) and total plasma IgG
levels (p=0.45).
Conclusions
This is the first study to demonstrate the presence of
cross-clade reactive anti-V3 antibodies and their associa-
tion with time in the plasma of HIV-1 infected Asian
Indians from north India.
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